Reuters logo
India's Unichem plans to sell drug unit to Mylan for $30 mln
February 15, 2013 / 12:25 PM / 5 years ago

India's Unichem plans to sell drug unit to Mylan for $30 mln

MUMBAI, Feb 15 (Reuters) - India’s Unichem Laboratories said on Friday it plans to sell a drug manufacturing plant located in central India to a unit of U.S.-based Mylan for 1.6 billion rupees ($29.7 million).

The deal is subject to the execution of a definitive agreement between the two drugmakers and regulatory approvals, Unichem said in a statement.

Shares in Unichem Laboratories rose 1.04 percent on Friday to 175.55 rupees when the wider Mumbai market fell 0.16 percent.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below